XenoPort, Inc. (NASDAQ:XNPT)

CAPS Rating: 2 out of 5

A biopharmaceutical company focused on developing a portfolio of internally discovered product candidates that utilize the body's natural nutrient transporter mechanisms to improve the therapeutic benefits of drugs.

Recs

0
Player Avatar projectchris (40.12) Submitted: 6/1/2011 9:38:27 AM : Outperform Start Price: $7.77 XNPT Score: -22.55

just tracking

Featured Broker Partners


Advertisement